Clinical Trials Directory
We created the Duke Clinical Research Volunteer Registry for people who would like to join clinical research studies. We will use this registry to contact you about available studies.
For more information or to sign up, visit us at:
https://redcap.duke.edu/redcap/surveys/?s=X4T7JKHPX4
A registry is a database of information (data) about patients living with a specific condition. Scientists study the information in the registry to increase what we know about the condition so we can develop better treatments in the future.
This registry will help us better understand lupus and how it is managed, including how different treatments work and their long-term safety.
We have created this repository (storehouse) as a way to securely store your data and samples for future research studies.
These data and samples help us to learn more about health, injury and disease that we hope will lead to improved care of patients.
We are doing this study to compare the usual treatment (surgery plus chemotherapy afterward) to using chemotherapy both before and after surgery.
We are doing this study to find out if infusing chemotherapy drugs directly into the hepatic artery (the blood vessel that supplies blood to the liver) is a better treatment option than standard chemotherapy for people who have colorectal cancer that has spread to the liver.
We are doing this study to compare the safety and effects of stopping the standard melanoma treatments of nivolumab + pembrolizumab or nivolumab + relatlimab at different times. We hope this study will help us discover certain markers from imaging and biopsies that can signal when it is the appropriate time to stop therapy.
We are doing this study to compare the usual treatments of surgery alone to using chemotherapy before surgery. We want to know if adding doxorubicin and ifosfamide chemotherapy for liposarcoma (LPS) or doxorubicin and dacarbazine chemotherapy for leiomyosarcoma (LMS) before surgery can improve the long-term survival for patients with these cancers.
We are doing this study to find out how different imaging techniques can help with the evaluation of glioblastoma.